Quality of emergence from anesthesia and incidence of vomiting with remifentanil in a pediatric population.
We conducted a randomized trial to compare the incidence of vomiting and the quality of emergence from anesthesia associated with the use of remifentanil versus a nonopiate. It was expected that remifentanil would provide smoother emergence from anesthesia with a comparably low rate of vomiting. The study sample consisted of 115 pediatric patients undergoing dental restoration and extraction who were randomly assigned to the nonopiate or remifentanil groups based on their hospital admission numbers. The nonopiate patients received sufficient desflurane to prevent movement, typically 7%-9%. The remifentanil group received remifentanil 0.2 microg x kg(-1) x min(-1) and enough desflurane to prevent movement, typically 3.2%-3.6%. A trained postanesthesia care unit nurse, blinded to the anesthetic technique, assessed the quality of emergence and incidence of vomiting. Sixty-three patients received remifentanil and 52 received the nonopiate. The groups were not significantly different in either quality of emergence or incidence of vomiting. Remifentanil provided results comparable to a nonopiate with no increase in emesis.


CONCLUSIONS
A randomized, controlled clinical trial of 115 patients undergoing dental restoration indicated that an anesthetic technique using remifentanil provided quality of emergence comparable to and no greater incidence of vomiting than a nonopiate technique.
Pinsker
M C
MC
Department of Anesthesia, Richmond Eye and Ear Hospital, Virginia, USA.
Carroll
N V
NV
D000758:Anesthesia; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D010880:Piperidines / Q000009:adverse effects*; D011183:Postoperative Complications / Q000139:chemically induced*; D000077208:Remifentanil; D014839:Vomiting / Q000139:chemically induced*
D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil